Financial Instruments and Risk Management (Tables)
|
3 Months Ended |
Dec. 24, 2022 |
Fair Value Disclosures [Abstract] |
|
Fair value of the Partnership's derivative instruments and their location in the condensed consolidated balance sheets |
The following summarizes the fair value of the Partnership’s derivative instruments and their location in the condensed consolidated balance sheets as of December 24, 2022 and September 24, 2022, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 24, 2022 |
|
|
As of September 24, 2022 |
|
Asset Derivatives |
|
Location |
|
Fair Value |
|
|
Location |
|
Fair Value |
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Commodity-related derivatives |
|
Other current assets |
|
$ |
11,761 |
|
|
Other current assets |
|
$ |
18,263 |
|
|
|
Other assets |
|
|
— |
|
|
Other assets |
|
|
16,430 |
|
|
|
|
|
$ |
11,761 |
|
|
|
|
$ |
34,693 |
|
|
|
|
|
|
|
|
|
|
|
|
Liability Derivatives |
|
Location |
|
Fair Value |
|
|
Location |
|
Fair Value |
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Commodity-related derivatives |
|
Other current liabilities |
|
$ |
12,569 |
|
|
Other current liabilities |
|
$ |
16,957 |
|
|
|
Other liabilities |
|
|
319 |
|
|
Other liabilities |
|
|
1,895 |
|
|
|
|
|
$ |
12,888 |
|
|
|
|
$ |
18,852 |
|
|
Reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs |
The following summarizes the reconciliation of the beginning and ending balances of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurement Using Significant Unobservable Inputs (Level 3) |
|
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
|
December 24, 2022 |
|
|
December 25, 2021 |
|
|
|
Assets |
|
|
Liabilities |
|
|
Assets |
|
|
Liabilities |
|
Beginning balance of over-the-counter options |
|
$ |
222 |
|
|
$ |
3,408 |
|
|
$ |
4,626 |
|
|
$ |
451 |
|
Beginning balance realized during the period |
|
|
(46 |
) |
|
|
(298 |
) |
|
|
(1,629 |
) |
|
|
— |
|
Contracts purchased during the period |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Change in the fair value of outstanding contracts |
|
|
(65 |
) |
|
|
308 |
|
|
|
(2,137 |
) |
|
|
(3 |
) |
Ending balance of over-the-counter options |
|
$ |
111 |
|
|
$ |
3,418 |
|
|
$ |
860 |
|
|
$ |
448 |
|
|
Effect of the Partnership's derivative instruments on the condensed consolidated statements of operations |
The effect of the Partnership’s derivative instruments on the condensed consolidated statements of operations for the three months ended December 24, 2022 and December 25, 2021 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 24, 2022 |
|
|
Three Months Ended December 25, 2021 |
|
Derivatives Not Designated as Hedging Instruments |
|
Unrealized Gains (Losses) Recognized in Income |
|
|
Unrealized Gains (Losses) Recognized in Income |
|
|
|
Location |
|
Amount |
|
|
Location |
|
Amount |
|
Commodity-related derivatives |
|
Cost of products sold |
|
$ |
(13,706 |
) |
|
Cost of products sold |
|
$ |
(33,505 |
) |
|
Fair value of the Partnership's recognized derivative assets and liabilities on a gross basis and amounts offset on the condensed consolidated balance sheets |
The following table presents the fair value of the Partnership’s recognized derivative assets and liabilities on a gross basis and amounts offset on the condensed consolidated balance sheets subject to enforceable master netting arrangements or similar agreements:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 24, 2022 |
|
|
As of September 24, 2022 |
|
|
|
|
|
|
|
|
|
Net amounts |
|
|
|
|
|
|
|
|
Net amounts |
|
|
|
|
|
|
|
|
|
presented in the |
|
|
|
|
|
|
|
|
presented in the |
|
|
|
Gross amounts |
|
|
Effects of netting |
|
|
balance sheet |
|
|
Gross amounts |
|
|
Effects of netting |
|
|
balance sheet |
|
Asset Derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity-related derivatives |
|
$ |
42,523 |
|
|
$ |
(30,762 |
) |
|
$ |
11,761 |
|
|
$ |
117,260 |
|
|
$ |
(82,567 |
) |
|
$ |
34,693 |
|
Liability Derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity-related derivatives |
|
$ |
43,650 |
|
|
$ |
(30,762 |
) |
|
$ |
12,888 |
|
|
$ |
101,419 |
|
|
$ |
(82,567 |
) |
|
$ |
18,852 |
|
|
Fair Value of the Partnership's Senior Notes |
Based upon quoted market prices (a Level 1 input), the fair value of the Senior Notes (also defined below in Note 10) of the Partnership are as follows:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
December 24, |
|
|
September 24, |
|
|
|
2022 |
|
|
2022 |
|
5.875% senior notes due March 1, 2027 |
|
|
336,000 |
|
|
|
336,375 |
|
5.0% senior notes due June 1, 2031 |
|
|
559,000 |
|
|
|
547,625 |
|
|
|
$ |
895,000 |
|
|
$ |
884,000 |
|
|